相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meningococcal carriage among a university student population - United States, 2015
Lucy Breakwell et al.
VACCINE (2018)
Challenges and opportunities for meningococcal vaccination in the developing world
Rouba Shaker et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature
Paul Balmer et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
Ray Borrow et al.
EXPERT REVIEW OF VACCINES (2017)
Improving accountability in vaccine decision-making
James Kenneth Timmis et al.
EXPERT REVIEW OF VACCINES (2017)
Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016
Lucy A. McNamara et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study
Iain T. R. Kennedy et al.
PLOS ONE (2017)
The humanistic and economic burden of chronic wounds: a protocol for a systematic review
Krister Jarbrink et al.
SYSTEMATIC REVIEWS (2017)
Cost-of-Illness Studies: An Updated Review of Current Methods
Eberechukwu Onukwugha et al.
PHARMACOECONOMICS (2016)
Deciphering the Burden of Meningococcal Disease: Conventional and Under-recognized Elements
Federico Martinon-Torres
JOURNAL OF ADOLESCENT HEALTH (2016)
The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines
Stephen I. Pelton
JOURNAL OF ADOLESCENT HEALTH (2016)
Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases
Chantal Edge et al.
JOURNAL OF INFECTION (2016)
Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany
Hannah Christensen et al.
VACCINE (2016)
Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France
Heloise Lecocq et al.
VACCINE (2016)
Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis
David D. Kim et al.
VALUE IN HEALTH (2016)
Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review
Melissa Desmedt et al.
VALUE IN HEALTH (2016)
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero (R)) against meningococcal B disease: A cost-effectiveness analysis
Roberto Gasparini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Lifetime cost of meningococcal disease in France: Scenarios of severe meningitis and septicemia with purpura fulminans
Steve Benard et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee
Drew Carter et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2016)
Cost of Illness of Multiple Sclerosis - A Systematic Review
Olivia Ernstsson et al.
PLOS ONE (2016)
Outcomes of Invasive Meningococcal Disease in Adults and Children in Canada Between 2002 and 2011: A Prospective Cohort Study
Manish Sadarangani et al.
CLINICAL INFECTIOUS DISEASES (2015)
The Economic Costs of Type 2 Diabetes: A Global Systematic Review
Till Seuring et al.
PHARMACOECONOMICS (2015)
Economic Impact of Meningococcal Outbreaks in Brazil and Colombia
D. Constenla et al.
Open Forum Infectious Diseases (2015)
Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
Marcello Tirani et al.
PLOS ONE (2015)
Cost of illness for bipolar disorder: a systematic review of the economic burden
Katja Kleine-Budde et al.
BIPOLAR DISORDERS (2014)
THE CLINICAL BURDEN AND PREDICTORS OF SEQUELAE FOLLOWING INVASIVE MENINGOCOCCAL DISEASE IN AUSTRALIAN CHILDREN
Bing Wang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada
Hong Anh T. Tu et al.
VACCINE (2014)
The costs associated with the public health management of a cluster of meningococcal infection in England
Dominique Letouze et al.
VACCINE (2014)
The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children
Bing Wang et al.
VACCINE (2014)
Costs of surviving meningococcal disease in Spain: Evaluation for two cases of severe meningitis and septicaemia
Josep Darba et al.
VACCINE (2014)
Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
Hannah Christensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Cost-of-illness studies: concepts, scopes, and methods
Changik Jo
CLINICAL AND MOLECULAR HEPATOLOGY (2014)
The burden and impact of severe and long-term sequelae of meningococcal disease
Andrew Vyse et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada
Julie A. Bettinger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
Hiltsje Hepkema et al.
PLOS ONE (2013)
The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review
Andrea Anonychuk et al.
PHARMACOECONOMICS (2013)
Systematic review of pneumococcal disease costs and productivity loss studies in Latin America and the Caribbean
Luciana Bahia et al.
VACCINE (2013)
Counting the Cost of Meningococcal Disease Scenarios of Severe Meningitis and Septicemia
Claire Wright et al.
PEDIATRIC DRUGS (2013)
Prospects for eradication of meningococcal disease
Simon Nadel
ARCHIVES OF DISEASE IN CHILDHOOD (2012)
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study
Russell M. Viner et al.
LANCET NEUROLOGY (2012)
A Review of the Cost of Atrial Fibrillation
Walter P. Wodchis et al.
VALUE IN HEALTH (2012)
REVIEW OF STATISTICAL METHODS FOR ANALYSING HEALTHCARE RESOURCES AND COSTS
Borislava Mihaylova et al.
HEALTH ECONOMICS (2011)
Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the United States
Keith L. Davis et al.
HUMAN VACCINES (2011)
Cost impact of complications in meningococcal disease Evidence from a United States managed care population
Keith L. Davis et al.
HUMAN VACCINES (2011)
Cost-of-Illness Studies A Guide to Critical Evaluation
Allison Larg et al.
PHARMACOECONOMICS (2011)
The burden of hospitalizations for meningococcal infection in Spain (1997-2008)
Ruth Gil-Prieto et al.
VACCINE (2011)
Hospital Costs, Length of Stay and Mortality Associated with Childhood, Adolescent and Young Adult Meningococcal Disease in the US
Keith Davis et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2011)
A web-based tool for adjusting costs to a specific target currency and price year
Ian Shemilt et al.
EVIDENCE & POLICY (2010)
Hospital admissions for meningococcal infection in Spain (1997-2005)
J. M. San Roman Montero et al.
JOURNAL OF INFECTION (2009)
State-Based Surveillance to Determine Trends in Meningococcal Disease
Carmen Clarke et al.
PUBLIC HEALTH REPORTS (2009)
Global epidemiology of meningococcal disease
Lee H. Harrison et al.
VACCINE (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Managing meningococcal disease in the United States: Hospital case characteristics and costs by age
Judith A. O'Brien et al.
VALUE IN HEALTH (2006)
An analytical framework for immunization programs in Canada
LJ Erickson et al.
VACCINE (2005)
Providing systematic guidance in pharmacoeconomic guidelines for analysing costs
P Jacobs et al.
PHARMACOECONOMICS (2005)
A checklist for retrospective database studies - Report of the ISPOR task force on retrospective databases
B Motheral et al.
VALUE IN HEALTH (2003)
分享论文
